Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · IEX Real-Time Price · USD
14.25
+0.22 (1.57%)
At close: Jul 12, 2024, 4:00 PM
14.28
+0.03 (0.21%)
After-hours: Jul 12, 2024, 7:35 PM EDT

Stoke Therapeutics Revenue

Stoke Therapeutics had revenue of $7.85M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $4.22M. In the year 2023, Stoke Therapeutics had annual revenue of $8.78M.

Revenue (ttm)
$7.85M
Revenue Growth
-46.10%
P/S Ratio
94.67
Revenue / Employee
$71,318
Employees
110
Market Cap
742.72M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20238.78M-3.63M-29.22%
Dec 31, 202212.41M--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Embecta 1.13B
InnovAge Holding 741.33M
Evolus 219.70M
Wave Life Sciences 112.91M
UroGen Pharma 84.30M
CureVac 64.13M
Revenue Rankings